Why Jim Cramer Is Excited About J&J's Vaccine Candidate
The Dow picked up steam in intraday trading following Pfizer (PFE) - Get Report and BioNTech's (BNTX) - Get Report U.K. vaccine rollout. The U.K. began distributing the vaccine starting this morning.
The U.S. Food and Drug Administration is meeting later this week to decide whether or not to grant Pfizer and BioNTech's vaccine an Emergency Use Authorization. If the FDA does approve the vaccine, then distribution in the country could begin within 24 hours, according to Health and Human Services Secretary Alex Azar.
The U.S. said it would have enough COVID-19 vaccine doses to let most Americans get inoculated by the summer. The New York Times reported that federal officials last summer turned down an offer from Pfizer to sell the country more doses of its vaccine.
WATCH: Everything Jim Cramer Is Watching in the Markets Tuesday
Latest Videos From TheStreet and Jim Cramer:
- Coronavirus: The Latest Numbers on the COVID-19 Pandemic
- Streaming Isn't Enough to Make Jim Cramer Buy AT&T Stock
- What Stimulus Checks Do and Don’t Mean For Your Taxes
- Time Is Right for Airbnb, DoorDash IPOs, Asset Manager Says
- Drivers of Disruption and Innovation in the PPE Space
- Why Jim Cramer Is Confident on a Vaccine Rollout
- Jim Cramer: How to Balance Stay-At-Home and Return to Normal Plays
